Study to establish the safety of reducing radiation dose in selected p16+ OPSCC patients receiving adjuvant radiation after Transoral Robotic Surgery (TORS) and neck dissection
Recruiting
18-99 years
All
Phase
2
104 participants needed
1 Location
Brief description of study
The main purpose of this research study is to determine the likelihood of cancer growing back in the throat or in the neck, 2 years after completion of radiation, if lower doses of radiation are used to a smaller area of the head and neck region, than is currently the standard of care.
Also, this study will assess radiation side effects and determine if there are differences in side effects and patient-reported quality of life (QOL) in patients treated with intensity modulated radiation therapy (IMRT) versus proton therapy.
The study will enroll a total of 104 subjects. You will be in the study from the time you consent to participate until approximately 2 years after completing radiation therapy.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Transoral Robotic Surgery,TORS,Oropharyngeal Squamous Cell Carcinoma,OPSCC
-
Age: Between 18 Years - 99 Years
-
Gender: All
Updated on
17 Sep 2024.
Study ID: 852738
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
